Stock Forecast

  HeartBeam, Inc. ( BEAT) Stock. Should you Buy or Sell?    $ 1.33

0.05 (3.62 %)



HeartBeam, Inc. Analysis

Updated on 10-09-2022
Symbol BEAT
Price $1.33
Beta 0.000
Volume Avg. $96.38 thousand
Market Cap $10.63 M
52 Week Range $1.12 - $5.47


HeartBeam, Inc. opened the day at $1.33 which is +'3.62 % on yesterday's close. HeartBeam, Inc. has a 52 week high of $5.47 and 52 week low of $1.12, which is a difference of $4.35. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $10.63 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy HeartBeam, Inc. for $10.63 M, it would take 15 years to get your money back. HeartBeam, Inc. are in the Health Information Services space which will have a sweet spot and industry standard for net profit multiples.



Price Chart


1 D | All


Financials




HeartBeam, Inc. Stock Forecast - Is HeartBeam, Inc. a Buy or Sell?


DCF ScoreStrong Buy
ROE ScoreStrong Sell
ROA ScoreStrong Sell
DE ScoreNeutral
PE ScoreSell
PB ScoreStrong Buy
Overall RecommendationNeutral

Growth and Value


PE Ratio -2.290
Dividend Yiel 0.000
Net Profit Margin 0.000


Valuing HeartBeam, Inc.


Price Book Value Ratio 1.208 Price To Book Ratio 1.208
Price To Sales Ratio 0.000 Price Earnings Ratio -2.290


How liquid is HeartBeam, Inc.


Current Ratio 12.647
Quick Ratio 12.044


Debt


Debt Ratio 0.079 Debt Equity Ratio 0.086
Long Term Debt To Capitalization 0.000 Total Debt To Capitalization 0.000



Latest news about HeartBeam, Inc.


HeartBeam, Inc. (BEAT) CEO Branislav Vajdic on Q2 2022 Results - Earnings Call Transcript

HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Jon Hunt - Chief Business Officer Rick Brounstein - Chief Financial Officer Conference Call Participants Bill Sutherland - The Benchmark Company Jason Kolbert - Dawson James Operator Greetings and welcome to the HeartBeam Second Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode.

Date : 12/08/2022

HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time

Date : 26/07/2022

HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022

Date : 25/05/2022

HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

Date : 18/05/2022

HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time

Date : 28/04/2022





About HeartBeam, Inc.


CEO :
Sector : Healthcare
Industry : Health Information Services

Website : https://www.heartbeam.com

Exchange : NASDAQ Capital Market

Description :

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.


My Newsletter

Sign Up For Updates & Newsletters